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Abstract
Accuratemeasurement of the composition of complex samples is key for the safety and
efficacy of a range of products used in daily life, with sample preparation a critical step
in this workflow. QuEChERS is one such method, however published protocols do not
explicitly address acidic, basic, neutral, and amphiphilic species in a single protocol and
often use extra steps or an alternative preparation to recover the breadth of chemical
types. Our work addresses this need by investigating the use of QuEChERS for mon-
itoring this wide range of chemistries within environmental solids and blood plasma,
using a protocol that can accommodate both milliliter and microliter sample volumes.
While published methods can require significant resource and time, our approach
offers a reduction in preparation time (for environmental samples), with the “micro-
QuEChERS” protocol offering a further reduction in cost. The analytical performance
of these methods were assessed using reversed-phase LC-MS and showed good accu-
racy, precision, and sensitivity for the expected concentrations in the tested applica-
tions. Target analytes of variable lipophilicity/acidity were extracted and isolated from
soil, with largely repeatable matrix effects < 15%RSD and recoveries of 39-100%. An
initial “proof-of-concept” investigation using the “micro-QuEChERS” protocol showed
reduced matrix enhancement (median value of 90%ME) for soil, and improved matrix
effects and recovery (>65%) for blood plasma. This novel sample preparation method
can therefore offer an improved approach with wider applicability providing “cleaner”
extracts than other methods used for high-throughput clinical analysis.
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1 INTRODUCTION
Advances in the analytical workflow have largely concerned instrumentation accuracy and sensitivity1; however, there remains a need to develop
sample preparation technology to meet the demands of “blue-sky” research and regulated industry.2 Ideally sample preparation strategies will
repeatedly provide extracts containing high amounts of the target analyte(s) for measurement without interference, while using low amounts of
resource and time to do so.1 However, a compromise is often encountered during development with only some of these desirable characteristics
achieved, with these depending on whether a targeted preparation or a “screen” of the sample for unknown materials (i.e. biomarker studies) is
required.1 Example complex mixtures include environmental and clinical samples and these have traditionally used multistep preparations with a
range of procedures and equipment, resulting in time and resource consumingmethods.1
With greater focus on links between environmental and public health, and increased regulation for pollution and waste management, the selec-
tion of environmental matrices, target chemistries and their (trace) amounts for analysis3,4,5 make the analytical challengemore difficult to address
without appropriate sample preparation solutions. For example, the introduction of theWater Framework Directive3 and Circular Economy legis-
lation (waste and landfill6) has increased the types of matrices requiring molecular (pollutant) characterization to include organisms, wastewater,
sludges, and receiving sediments.3 These regulations are evidence-driven with substances of concern and their environmental limits4,5 continu-
ally evolving to protect environmental and public health. With eight pharmaceuticals considered as pollutants on a legislative “watch list”5,7 the
scope of monitoring programs has expanded to include other medicinal analytes within waste materials.8 These may cover a range of classes with
high usage (and perceived disposal) rates (e.g. diphenhydramine, carbamazepine, erythromycin, etc) and lipophilicity (log Kow, log P, or Kd), with
the latter enabling sorption to sludge and/or bioaccumulation within soil and biota, respectively.9,10 Given the significant re-use of treated sewage
sludge as agricultural fertilizer (80%)11 and the proposed effects on agricultural soil (e.g. antimicrobial resistance12), it is essential that pollutants
are accurately measuredwithin these samples.
Recognized methods for analyzing environmental matrices such as soil and wastewater are generally laborious multistep procedures using a
range of techniques and equipment, rendering them unsuitable for high-throughput analysis.9,10 Environmental solids are particularly challenging
due to the myriad of analytes present and the sorption of trace material to more abundant species (e.g. humic acids); sample preparation therefore
requires additional stages to displace the trace analyte resulting in some extractions taking hours per sample.9,10 When tested in-house, standard
methods have also exhibited poor repeatability for pharmaceuticals (data not shown) further highlighting the need for a simple, rapid, and reliable
sample preparation with minimal matrix effects on the measured signal and high recovery. Similar to environmental samples, clinical matrices are
complex with target molecules (such as pharmaceuticals) often present in trace amounts.1,2 Again, a compromise is often encountered between a
more targeted multistep preparation to ensure highly accurate and sensitive measurements, or a quick method to remove an impurity class (e.g.
protein precipitation) that relies on instrumentation sensitivity, often resulting in increased matrix interference and instrument down-time due to
fouling.1,13 Therefore, for qualitative screening of clinicalmatrices (e.g. biomarker studies) where an unbiased but quick approach is required (given
the substances of interest are unknown), there remains a need for a low cost, quick preparationmethod capable of extracting a range of analytes at
trace concentrations without fouling downstream instrumentation.
The QuEChERS sample preparation method is a two-step process originally developed for the extraction of acidic and basic pesticides
from foodstuffs,14 involving a liquid extraction (typically using acetonitrile) and a dispersive solid-phase extraction (dSPE) using primary-
secondary amine (PSA), C18, and/or graphitized carbon black (GCB) sorbents to target the removal of abundant interferences (e.g. humic
acids, lipids, etc). This less biased approach provides the distinct advantage of method flexibility for screening environmental and clinical sam-
ples and is evidenced by recent work concerning specific analyte classes (e.g. pharmaceuticals15,16,17,18,19,20,21,22 and surfactants23,24,25,26), and
environmental15,16,17,21,24,27,28,22,29,30 and clinical matrices.19,20,26,31,32,33,34 However, these studies have been varied in their approach and have
not explicitly addressed the breadth of analyte classes as a single method in samples such soil and blood plasma without using additional steps to
the protocol or alternative preparations to recover the analytes. Therefore, there remains a need to understand the chemical breadth ofQuEChERS
for extracting acidic, basic, neutral, and amphiphilic analytes from these environmental and clinical matrices as a single preparative protocol. Pilot
work has also shown potential to reduce the scale of QuEChERS to minimize resource (e.g. two pharmaceuticals in biota,17 bisphenol A in urine,33
and pesticides in tissues32); however, the capability of (micro-)QuEChERS in extracting a range of acidic, basic, neutral, and amphiphilic medicinal
analytes from blood plasma again remains unknown.
Given its successful application to similar complex samples and the extraction of selected pharmaceuticals and pesticides, we believed QuECh-
ERS would provide an alternative single protocol extraction for the range of anticipated chemistries (acidic, neutral, basic, and amphiphilic) in soil
and plasma, as a quicker and cheaper approach, with less matrix interference versus traditional methods described above. In readiness for the
eventual application, the sample preparation was developed as part of a quantitative analytical method using an internal standard (IS) approach.
For smaller-scale extractions (potential high-throughput formats and automation), the optimized protocol was also investigated as a “micro-
QuEChERS” approach for implementation at lower cost.
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2 METHODS AND MATERIALS
2.1 Chemicals and materials
To represent acidic, basic, and neutral pharmaceuticals diclofenac sodium, loratadine, acetaminophen, carbamazepine, citalopram hydrobromide,
propranolol hydrochloride, fluoxetine hydrochloride, diphenhydramine hydrochloride, and erythromycin were purchased from Sigma–Aldrich
(Poole, UK) and assigned according to their predicted state at pH 7 (see Supporting Information). For the amphiphilic (surfactant) class, quaternary
ammonium compounds (QACs) were purchased from Sigma–Aldrich (Poole, UK) and included benzyldimethyldodecylammonium chloride (BAC-
C12), benzyldimethyltetradecylammonium chloride (BAC-C14), and an aliphatic surfactant hexadecyltrimethylammonium chloride (HDTMA).
While as ISs acetaminophen-(methyl-d3) and 10,11-dihydrocarbamazpine, pronethalol hydrochloride, and talopram hydrochloride were purchased
from Tocris (Abingdon, England) and benzyldimethyltetradecylammonium chloride-d7 (BAC-C14-d7) from Toronto Research Chemicals (Ontario,
Canada). For sample preparation, modifiedQuEChERS extraction kits were obtained fromBiotage (Uppsala, Sweden) with formic acid, acetonitrile,
and water (HPLC-grade) from Fisher Scientific (Loughborough, UK). As complex matrices for proof-of-concept testing, garden soil was collected
from an undisclosed location inWestWales and blood plasma sourced from Seralab (West Sussex, UK).
2.2 Instrumentation
Chromatographic separation was carried out using a Thermo Scientific (Hemel Hempstead, UK) liquid chromatography (LC) system consisting of
a Micro AS autosampler and MSPump Plus, with a reversed phase Waters (Elstree, UK) Xselect HSS T3 LC column (1 × 100 mm, 3.5 µm) and a
Phenomenex KrudKatcher Ultra online filter (Macclesfield, UK). The LC system was controlled using Xcalibur 2.0.7 software (Thermo Scientific)
with detection performed using a dual mass spectrometry approach to accommodate the range of scan speeds and sensitivities anticipated for
the differing analyte concentrations within the sample types (established from in-house screening). For the more abundant amphiphilic analytes,
a Thermo Finnigan LCQ ion trap mass spectrometer (Hemel Hempstead, UK) was operated with an ESI source in positive ion mode using Xcalibur
2.0.7 software, while, for the broader suite of pharmaceuticals, a faster scanningWaters Micromass ZQ4000 single quadrupole (Manchester, UK)
mass spectrometer, again operatingwith an ESI source in positive ionmode, was used to capture sufficient data for quantitation usingMassLynx 4.0
software. Data processing was undertaken with relevant instrumentation software andMicrosoft Excel 2010.
2.3 Stock and working solutions
Where possible stock solutions (1 mg/mL) were prepared in water to minimize degradation during storage while erythromycin, loratadine, carba-
mazepine, 10,11-dihydrocarbamazepine and QACs were prepared in 100% acetonitrile due to limited water solubility. Calibration standards were
made from the stock solutions as a pharmaceutical and QAC mixture in 50:50 acetonitrile/water (1-400 ng/mL for each pharmaceutical (apart
from acetaminophen (5-400 ng/mL) and 2-80 ng/mL for QACs) with a relevant internal standard (100 ng/mL for pharmaceuticals and 20 ng/mL for
QACs). Quality control (QC) samples to test the quantitative performance of the method were similarly prepared at four concentrations within
the calibration range; 15, 25, 100, and 350 ng/mL for pharmaceuticals; and 8, 20, 60, and 80 ng/mL for QACs. A “double” blank (SB) contain-
ing just solvent and an IS blank (S0) were also included to confirm method selectivity by detecting sample carryover and analyte contamination,
respectively.
2.4 Sample preparation conditions
A novel QuEChERS method was developed using 4 g magnesium sulphate (MgSO4) and 1.5 g of sodium acetate (NaOAc) as the initial extraction
step, followed by dSPE using 150 mg PSA and 900 mg MgSO4. The extraction performance was assessed by determining matrix effects (%ME),
recovery (%REC), and process efficiency (%PE), comparing samples whereby analyte is spiked before extraction (SBE), after extraction (SAE) and a
non-extracted standard of equivalent concentration35 (see Supporting Information for details). Triplicate samples containing a mixture of pharma-
ceutical and QAC analytes at a concentration of 100 ng/mL and 60 ng/mL (and relevant IS) were extracted; 10 mL of acetonitrile and the contents
of the initial extraction tube were added to each sample, shaken for 1 min, centrifuged for 5 min, with the supernatant added to the dSPEmaterial,
and vortexed for 1 min and centrifuged for a further 5 min. The post-extraction supernatant was transferred to a fresh vial, evaporated to dryness
under nitrogen, and reconstituted in 50:50 water/acetonitrile. While for “micro-QuEChERS”, a simplified approach of reducing all sample volumes,
reagents, and extractionmedia by a scaling factor of 1/8 was used.
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2.5 Liquid chromatography-mass spectrometry analysis
Samples were kept at 4◦C prior to injecting 5 µL on-column and separated using a gradient elution program of 0.1% formic acid in water (A) and
acetonitrile (B) at a flow of 50 µL/min (95% A:5% B at 0-2 min, with %B increasing linearly over 28 min) based on prior studies15,36 and an in-
house general screening method. Prior to method development the mass spectrometers were optimized for acquiring the target precursor and
fragment ions using a combination of full mass scan and selected reaction/ion monitoring modes to facilitate qualitative and quantitative analyses
(see Supporting Information for details). The integratedpeak area from the relevant ion chromatogramwasused to evaluate the sample preparation
and generate calibration graphs over selected concentration ranges (estimated from in-house sample screening) to confirm the amounts recovered
from the extraction (see Supporting Information).
3 RESULTS AND DISCUSSION
3.1 Analytical method characterization
3.1.1 Analytical selectivity and chromatographic repeatability
Each target analyte and internal standard was identified by the anticipated protonated molecule, isotope pattern, and chromatographic retention
time; only diclofenac and talopram (IS) did not exhibit mass selectivity (m/z 296) however, these had notable differences in isotope pattern (chlo-
rine) and baseline chromatographic separation indicative of their different hydrophobicity on column. Given this dependence on chromatographic
selectivity, retention time repeatability was determined using sequential injections of a standard mixture over 2 days and by calculating the rela-
tive standard deviation (%RSD) and variance (using a two-tailed F-test), respectively. The data showed repeatable chromatography for all analytes
(with no detectable carryover) on both days (RSDs < 5%) and no significant difference determined between the 2 days; largely chromatographic
stability improved for acidic/neutral/basic analytes with prolonged use (lower %RSDs for day 2, see Supporting Information) indicating a further
settling of chromatographic conditions with time. For amphiphilic analytes stable chromatography was also observed, with typical repeatability
of <0.23%RSD and no significant difference in chromatography over separate days of analysis. To understand the error associated with sample
injection for method quantitation, injection repeatability was also determined using the chromatographic peak area for each analyte. Again, good
repeatability was observed (<12%RSD) with stable chromatographic and ionization conditions for assessing quantitative performance (see Sup-
porting Information).
3.1.2 Calibration statistics, limit of detection (LOD), precision, and accuracy
To establish if adjustment of the regression function was required to accommodate any heteroscedasticity within the calibration data, the percent-
age relative error (%RErr) of the calculated and theoretical concentrations for selectedweighting factorswas determined, and the simplest weight-
ing factor of lowest %RErr37 with R2 ≥ 0.98 chosen as the most suitable regression function. As expected for the selected instrumentation, 1/x
proved the most suitable for analyte quantitation (see Supporting Information) with good linearity observed over the measured dynamic range(s)
for most analytes following adjustment. For the LOD, values were initially calculated using statistical and empirical methods, however, the former
method assumes data are homoscedastic38 and so was omitted for further work. Pleasingly, empirical LODs showed good sensitivity at <1 ng/mL
apart from acetaminophen and HDTMA (5.81 and 1.88 ng/mL, respectively) however, all were considered suitable for the anticipated concentra-
tion range within relevant samples (in-house data). For quantitation, the method precision and accuracy were characterized using replicate QCs at
four concentrations within the dynamic range (see Supporting Information for more detail). Despite the higher precision values observed for the
amphiphilic species (indicative for ion trap data), the method remained reliable for quantifying within the concentration range with largely good
precision and accuracy determined for each analyte (≤20.5%RSD andmean accuracy< 16.0%) at all QC concentrations.
3.2 QuEChERS sample preparation method evaluation
3.2.1 Method optimization
Initial feasibility and optimization of theQuEChERS extraction for acidic, neutral, basic, and amphiphilic analyteswere carried out using a simplified
water matrix and evaluated according to the duration of extraction (as an assessment of cost), matrix effects (%ME), analyte recovery (%REC), and
overall process efficiency (%PE), where the method would ideally exhibit reliably lowmatrix interference and high recovery (both with RSD< 20%
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F IGURE 1 Comparison between themean percentagematrix effects and recovery (with standard error bars) of acidic, neutral, basic and
amphiphilic analytes calculated for the spiked solvent and spiked soil samples followingQuEChERS extraction (n= 3). The dashed line indicated
the zeromatrix interference of the signal (i.e. 100%matrix effect)
relevant for the tested applications) of the measured analyte for high process efficiency. Given the minimal equipment required for QuEChERS,
multiple sampleswere rapidly extracted (facilitating replicate analyses), enabling a reduction in analyst time (fromhours to∼20min per sample) and
a saving of extraction costs of>60% (versus recommended solid phase extraction cartridges10) for environmental solids. From an initial study with
the commercially available buffered EN extraction method, the presence of sodium chloride (counter ion) resulted in undesirable peak broadening
and poor recovery for the majority of acidic, neutral, and basic species, and therefore, alternative reagent mixtures were investigated. Of these,
4 g of MgSO4 with 1.5 g NaOAc (a mixture of the EN and AOAC extraction) followed by PSA dSPE (to remove acidic interferences anticipated in
the samplematrices) withMgSO4 proved promising, showing repeatable sample preparation formost analytes selected (%RSD≤20%) andminimal
matrix effects (median of 106%ME) as shown in Figure 1. The exceptions to this were acetaminophen-(methyl-d3), talopram, diphenhydramine,
propranolol, and HDTMA, where matrix enhancement was observed; however, given the good repeatability (%RSDs < 14%) for all analytes this
signal enhancement may be accounted for, ensuring a more accurate analyte recovery and process efficiency. This novel QuEChERS blend also
showed repeatable recovery (%RSD < 20%) for the majority of analytes apart from diclofenac; while the result for diclofenac is unsurprising (i.e.
likely retention on the cationic dSPE at the sample pH (<8)), the remaining data indicates a high level of robustness for alternative chemistries.
Pleasingly, QuEChERS also offers potential to mitigate this loss, with flexibility to include alternative dSPE material (such as anion exchange given
low analyte recoveries observed when using C18 in-house) for the parallel clean-up of the initial supernatant. Interestingly, when considering the
remaining analytes all classes had similar mean recoveries (∼40%) with slightly higher values observed for amphiphilic species (∼55%); this again,
supports the use ofQuEChERS as a preparativemethod for analyzing different chemistries as a screen, with reasonable process efficiency and little
optimization.
3.2.2 Application of the novel QuEChERS to complex samples: Environmental solids
The novel QuEChERS extraction was tested using locally sourced garden soil as an example control matrix for contaminated agricultural soil
or wastewater sludge cake. These sample matrices typically contain large amounts of non-volatile substances such as inorganic salts and
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macromolecular organic structures that include fulvic and humic acids. These latter species can behave as acidic substances (negatively charged),
contributing to signal suppression of the target analytes,39 and be particularly problematic for those with nonpolar character given they can elute
at similar chromatographic conditions. Admittedly, there is significant body of work investigating QuEChERS for the extraction of pesticides from
soils however, those concerning a broader range of target analytes are typically partial QuEChERS protocols (i.e. initial extraction) with relevant
analytes prone to significant suppression, even when combined with further preparative steps such as a heptane solvent extraction and cartridge
SPE24 or even dual cartridge SPE.22 Recent studies involving a complete QuEChERS protocol have been undertaken more successfully for vet-
erinary drugs and selected pharmaceuticals in soil; however, these required an additional filtration step and dSPE materials, and signal suppres-
sion, while albeit less, remained.29,30 Given this, there continued to be a case to investigate the potential improved performance of our novel
QuEChERS blend to extract the breadth of chemistries with less suppression and increased sample preparation resource (and time) of a dual SPE
protocol.
To test this approach, control soil was fortifiedwith analyte and ISmixtures (apart from diclofenac due to poor recovery in solvent) to determine
the matrix effects and recovery. As expected, there was greater evidence of matrix effects for each analyte but, pleasingly most measurements
showed little suppression (largely enhancement) with a median value of 113%ME (see Figure 1), supporting our initial hypothesis and dSPE selec-
tion for acidic interferences, and improved repeatability with RSDs < 15%. Unfortunately, there is limited published repeatability data for allied
work30 and so a “true” comparison of performance with similar methods is difficult to undertake; however, given the consistency of performance is
necessary formethod robustness and “normalizing” the recovery formatrix effects, this precision is highly desirable as it enables the determination
of quantified amounts without suppression (or enhancement) adversely influencing the data. Interestingly, there continues to be no apparent bias
with the extraction of chemical class using this protocol further supporting the application of QuEChERS as a screening method for samples where
the target extraction analyte is undecided or unknown. For the different analytes, recovery was largely repeatable (< 18%RSD) and of comparable,
if not, improved performance when extracted from soil. For analytes tested with the standard EPA method within biosolids,10 this new protocol
also showed improved repeatability of analyte recovery for carbamazepine, diphenhydramine, and fluoxetine, although this was at a compromise
of a lower recovery (39.8-100.1%). However, lower recoveries have been reported for some of the tested analytes in other work using the EPA
method, with values, pleasingly, more comparable to this novel QuEChERS protocol.40 When compared to established QuEChERS-based methods
that involving additional clean-up steps,22,30 better or comparable recoveries were also observed formost analytes common to these studies, high-
lighting the potential gain of this method. Admittedly, higher recoveries have been observed for carbamazepine,22 citalopram, and fluoxetine30;
however, these protocols were designed for a more targeted class of analytes, and presented limited repeatability data, making it difficult to fully
benchmark to ourmethod.
In summary, this new QuEChERS method has shown potential for extracting the majority of analytes tested with desirable characteristics such
as extraction repeatability, minimal inherent matrix effects, reasonable analyte recovery (and process efficiency), and a short extraction time. For
use as an environmental protocol, it offers a reduction in analyst time from hours to ∼20 min and extraction costs by >60% (of solely extraction
cartridges) per sample, key to the future adoption of themethod.
3.2.3 Scalability of the novel QuEChERS method: “micro-QuEChERS”
The feasibility of this approachwas based on preliminarywork undertaken for a limited selection of pharmaceuticals (two) in biota,17 bisphenol A in
urine33 and pesticides in tissues.41,32 Typically, sample availability for environmental analyses are not a concern, however, for handling “hazardous”
wastewater smaller sample sizes offer health and safety benefits by de-risking the measurement of these materials. Also, despite these “proof-of-
concept” studies, the capability of QuEChERS in extracting blood plasma for a broader range ofmedicinal compounds has remained unknown, even
with a continued need for cleaner alternatives to “simple” clinical preparativemethods. To assess the potential for extractingmedicinal compounds
from blood plasma and soil, a feasibility study of a “micro-QuEChERS” extraction using this novel blend was carried out; this involved using lower
sample volumes and extraction materials to provide a method that further reduces matrix effects (due to less matrix material) and operational
cost. As expected, matrix effects (including enhancement) decreased for most analytes versus the larger-scale QuEChERS approach with an over-
all median value of 90%ME, while maintaining the benefit of repeatability (RSD < 16%). However, despite the method showing largely repeatable
recovery (i.e. ±20%) for each analyte the values were somewhat lower than anticipated (26-59%), with erythromycin and acetaminophen unde-
tectable following extraction regardless of sample matrix, indicating a decrease in extraction efficiency for these analytes (see Figure 2). Of the
remaining analytes, the method performed very well for the amphiphilic class with similar recoveries to larger-volume QuEChERS, showing signif-
icant promise for the scalability of our method in extracting these analytes in soil. However, the “micro-QuEChERS” protocol showed the greatest
promise when extracting the selected analytes from blood plasma; largely repeatable matrix effects and recovery were observed with 19% sup-
pression and significantly higher recoveries for all analyte classes. This is particularly encouraging for clinical applications given quicker preparation
methods are typically limited in the level of analyte recovery and matrix removal (e.g. lack of phospholipid extraction with protein precipitation),
with the latter often resulting in significant matrix suppression (e.g.> 50%),42-44 with more limited sample availability requiring methods compati-
ble with low(er) sample volumes.
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F IGURE 2 Comparison between themean percentagematrix effects and recovery (with standard error bars) of acidic, neutral, basic and
amphiphilic analytes calculated for the spiked soil and spiked blood plasma samples followingmicro-QuEChERS extraction (n= 3). The dashed line
indicated the zeromatrix interference of the signal (i.e. 100%matrix effect)
This study indicates that the QuEChERS method can be robust in extracting a range of analytes (particularly amphiphilic species) from complex
substances of high lipophilicity and organic content, such as soil and blood plasma, with flexibility in terms of sample volumes for the extraction.
The method therefore offers promise for improving the handling of other environmental matrices of high organic content, such as wastewater
effluent and sludge cake, or clinical samples (e.g. cerebrospinal fluid), potentially enabling the in-process monitoring of pollutants or therapeutics,
respectively, at reduced cost.
4 CONCLUDING REMARKS
Recognized sample preparationmethods for analytes present in trace amountswithin complex samples (e.g. environmental (semi) solids and bioflu-
ids) are typically multistep, time- and resource-consuming extractions, with some used for environmental solids unsuitable for high-throughput
work, taking hours/sample. Unlike these protocols, QuEChERS has shown to be a time-saving sample preparation method for some analyte classes
but published work has not explicitly covered the breadth of acidic, basic, neutral, and amphiphilic analytes as a single protocol. To the best of the
authors’ knowledge, this study is the first to address this need, showing the applicability of QuEChERS for extracting analytes of medicinal use
(e.g. pharmaceuticals and biocides) from complex matrices as a single preparative method. Specifically, the protocol extracted analytes of variable
lipophilicity/acidity from soil with largely repeatable matrix effects and recoveries, offering a quicker approach for environmental screening to
inform future policy. To minimize sample handling risks and meet the demand for lower sample volumes (e.g. clinical applications), a reduced-scale
“micro-QuEChERS” was also developed for soil and blood plasma. Interestingly, this showed reducedmatrix enhancement, although analytes were
recovered in lower amounts from soil than anticipated; however, and most pleasingly, all analytes were consistently extracted from blood plasma
with improved matrix effects and recoveries, offering a promising method for clinical work. This novel sample preparation therefore not only pro-
vides amore efficient extraction for environmental matrices, with cost savings in terms of time and labor, but a quick “cleaner” alternative to “dilute
and shoot” or protein precipitation for high-throughput clinical work.
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